Phillip Frost, M.D. 13D and 13G filings for Niagen Bioscience Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-02 4:03 pm Sale |
2021-02-22 | 13D | Niagen Bioscience Inc NAGE |
Phillip Frost, M.D. | 2,351,521 3.800% |
-900,000 (-27.68%) |
Filing |